New drug could help regrow hair in severe alopecia
NCT ID NCT07311564
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a drug called LAD603 in 136 adults with severe to very severe alopecia areata, a condition causing significant hair loss. Participants will receive either the drug or a placebo to see if it helps regrow hair and is safe. The main goal is to measure changes in hair loss scores over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LAD603
- What this could lead to
- If it works, this could point toward a new treatment option for people with severe hair loss from alopecia areata.
- What could go wrong
- This is an early Phase 2 trial with only 136 participants, so results may not apply to everyone. The drug may not work better than placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Investigator Site 1
RECRUITINGOmaha, Nebraska, 68144, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill help teens regrow hair lost to alopecia?
- Can allergy and glaucoma drugs regrow hair when delivered by microneedling?
- Can a daily pill bring back hair in severe alopecia?
- Can Real-World data unlock better skin disease care?
- Can a daily pill regrow hair in alopecia areata? a trial seeks answers
- Blood test may reveal hidden clues to hair loss severity